Comments
Loading...
Crinetics Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:CRNX | Benzinga
Crinetics Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.940
Quarterly Revenue Estimate
$12.50K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.04M
Analyze the earnings history of Crinetics Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals | -$0.93 | -$0.94 | — | — | $640.00K | $12.50K | — | — | 05/08/2025 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.90 | -$0.89 | -$0.88 | 1.12% | $0.00 | $727.27K | $0.00 | -100.00% | 02/27/2025 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$1.01 | -$0.91 | -$0.96 | -5.49% | $346.00K | $240.00K | $0.00 | -100.00% | 11/12/2024 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.94 | -$0.86 | -$0.94 | -9.30% | $988.00K | $460.00K | $399.00K | -13.26% | 08/08/2024 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.85 | -$0.81 | -$0.93 | -14.81% | $2.68M | $260.00K | $640.00K | 146.15% | 05/09/2024 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.84 | -$0.86 | -$0.90 | -4.65% | $709.00K | $260.00K | $0.00 | -100.00% | 02/28/2024 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.78 | -$0.91 | -$1.01 | -10.99% | $458.00K | $120.00K | $346.00K | 188.33% | 11/07/2023 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.81 | -$0.86 | -$0.94 | -9.30% | $439.00K | $560.00K | $988.00K | 76.43% | 08/08/2023 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.73 | -$0.82 | -$0.85 | -3.66% | $3.13M | $300.00K | $2.68M | 793.00% | 05/04/2023 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.68 | -$0.82 | -$0.84 | -2.44% | $1.08M | $250.00K | $709.00K | 183.60% | 02/28/2023 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.73 | -$0.83 | -$0.78 | 6.02% | $0.00 | $170.00K | $458.00K | 169.41% | 11/14/2022 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.70 | -$0.67 | -$0.81 | -20.90% | $0.00 | $600.00K | $439.00K | -26.83% | 08/12/2022 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.69 | -$0.58 | -$0.73 | -25.86% | $0.00 | — | $3.13M | — | 05/12/2022 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.66 | -$0.62 | -$0.68 | -9.68% | $0.00 | — | $1.08M | — | 03/30/2022 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.56 | -$0.70 | -$0.73 | -4.29% | $0.00 | — | $0.00 | — | 11/05/2021 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.53 | -$0.61 | -$0.70 | -14.75% | $0.00 | — | $0.00 | — | 08/10/2021 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.71 | -$0.66 | -$0.69 | -4.55% | $71.00K | — | $0.00 | — | 05/06/2021 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.60 | -$0.58 | -$0.66 | -13.79% | $321.00K | — | $0.00 | — | 03/30/2021 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.60 | -$0.53 | -$0.56 | -5.66% | $505.00K | — | $0.00 | — | 11/06/2020 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.51 | — | -$0.53 | — | $0.00 | — | $0.00 | — | 08/07/2020 | Get Alert |
| CRNX | Crinetics Pharmaceuticals | -$0.37 | — | -$0.71 | — | $367.00K | — | $71.00K | — | 05/08/2020 | Get Alert |
Crinetics Pharmaceuticals (CRNX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.88 | $-0.89 | 1.12 % |
| Q3 | 2024-11-12 | $-0.96 | $-0.91 | -5.49 % |
| Q2 | 2024-08-08 | $-0.94 | $-0.86 | -9.30 % |
| Q1 | 2024-05-09 | $-0.93 | $-0.81 | -14.8 % |
Crinetics Pharmaceuticals (CRNX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $0 | $727.27K | -100.0 % |
| Q3 | 2024-11-12 | $0 | $240.00K | -100.0 % |
| Q2 | 2024-08-08 | $399.00K | $460.00K | -13.3 % |
| Q1 | 2024-05-09 | $640.00K | $260.00K | 146.2 % |
FAQ
When is Crinetics Pharmaceuticals (NASDAQ:CRNX) reporting earnings?
Crinetics Pharmaceuticals (CRNX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Crinetics Pharmaceuticals (NASDAQ:CRNX)?
The Actual EPS was $-0.88, which beat the estimate of $-0.89.
What were Crinetics Pharmaceuticals’s (NASDAQ:CRNX) revenues?
The Actual Revenue was $0K, which missed the estimate of $727.3K.
Browse earnings estimates, EPS, and revenue on all stocks.